Bridgebio Pharma Stock Math Operators Lowest value over a specified period

BBIO Stock  USD 65.50  0.98  1.47%   
BridgeBio Pharma math operators tool provides the execution environment for running the Lowest value over a specified period operator and other technical functions against BridgeBio Pharma. BridgeBio Pharma value trend is the prevailing direction of the price over some defined period of time. The concept of trend is an important idea in technical analysis, including the analysis of math operators indicators. As with most other technical indicators, the Lowest value over a specified period operator function is designed to identify and follow existing trends and Jazz Pharmaceuticals PLC. Math Operators module provides interface to determine different price movement patterns of similar pairs of equity instruments such as Jazz Pharmaceuticals PLC and BridgeBio Pharma. Please specify Time Period to run this model.

The output start index for this execution was one with a total number of output elements of sixty. The Lowest value over a specified period line plots minimum value of BridgeBio Pharma price series.

BridgeBio Pharma Technical Analysis Modules

Most technical analysis of BridgeBio Pharma help investors determine whether a current trend will continue and, if not, when it will shift. We provide a combination of tools to recognize potential entry and exit points for BridgeBio from various momentum indicators to cycle indicators. When you analyze BridgeBio charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.

About BridgeBio Pharma Predictive Technical Analysis

Predictive technical analysis modules help investors to analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of BridgeBio Pharma. We use our internally-developed statistical techniques to arrive at the intrinsic value of BridgeBio Pharma based on widely used predictive technical indicators. In general, we focus on analyzing BridgeBio Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build BridgeBio Pharma's daily price indicators and compare them against related drivers, such as math operators and various other types of predictive indicators. Using this methodology combined with a more conventional technical analysis and fundamental analysis, we attempt to find the most accurate representation of BridgeBio Pharma's intrinsic value. In addition to deriving basic predictive indicators for BridgeBio Pharma, we also check how macroeconomic factors affect BridgeBio Pharma price patterns. Please read more on our technical analysis page or use our predictive modules below to complement your research.
 2025 2026 (projected)
Dividend Yield3.11E-43.98E-4
Price To Sales Ratio30.0528.55
Hype
Prediction
LowEstimatedHigh
62.4865.5368.58
Details
Intrinsic
Valuation
LowRealHigh
58.9578.8681.91
Details
Naive
Forecast
LowNextHigh
61.4564.5067.55
Details
19 Analysts
Consensus
LowTargetHigh
91.04100.05111.05
Details

Become your own money manager

As an individual investor, you need to find a reliable way to track all your investment portfolios' performance accurately. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing you full analytical transparency into your positions, our tools can tell you how much better you can do without increasing your risk or reducing expected return.

Did you try this?

Run Economic Indicators Now

   

Economic Indicators

Top statistical indicators that provide insights into how an economy is performing
All  Next Launch Module

Trending Themes

If you are a self-driven investor, you will appreciate our idea-generating investing themes. Our themes help you align your investments inspirations with your core values and are essential building blocks of your portfolios. A typical investing theme is an unweighted collection of up to 20 funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of equities with common characteristics such as industry and growth potential, volatility, or market segment.
Macroaxis Index Idea
Macroaxis Index
Invested over 90 shares
SRI Sustainable Growth Idea
SRI Sustainable Growth
Invested over 90 shares
ESG Investing Idea
ESG Investing
Sold few shares
Corona Opportunity Idea
Corona Opportunity
Invested over 90 shares
When determining whether BridgeBio Pharma offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of BridgeBio Pharma's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Bridgebio Pharma Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Bridgebio Pharma Stock:
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in BridgeBio Pharma. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in gross domestic product.
To learn how to invest in BridgeBio Stock, please use our How to Invest in BridgeBio Pharma guide.
You can also try the Investing Opportunities module to build portfolios using our predefined set of ideas and optimize them against your investing preferences.
Will Biotechnology sector continue expanding? Could BridgeBio diversify its offerings? Factors like these will boost the valuation of BridgeBio Pharma. Projected growth potential of BridgeBio fundamentally drives upward valuation adjustments. Accurate valuation requires analyzing both current fundamentals and future growth trajectories. Every BridgeBio Pharma data point contributes insight, yet successful analysis hinges on identifying the most consequential variables.
Earnings Share
(3.78)
Revenue Per Share
2.621
Quarterly Revenue Growth
25.212
Return On Assets
(0.34)
Return On Equity
(17.90)
BridgeBio Pharma's market price often diverges from its book value, the accounting figure shown on BridgeBio's balance sheet. Smart investors calculate BridgeBio Pharma's intrinsic value - its true economic worth - which may differ significantly from both market price and book value. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. Since BridgeBio Pharma's trading price responds to investor sentiment, macroeconomic conditions, and market psychology, it can swing far from fundamental value.
It's important to distinguish between BridgeBio Pharma's intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding BridgeBio Pharma should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. However, BridgeBio Pharma's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.